Once-weekly semaglutide in adults with overweight or obesity

Human Clinical2021human clinicalSemaglutide

Wilding et al. · PubMed/NEJM

Abstract / Summary

Demonstrated incredibly significant and enduring systemic body fat and weight load reductions consistently across massively diversified international populations.

Methods

Investigated as a human clinical in the field of metabolic research. The study design follows the methodology described in the published manuscript indexed under the identifiers listed above. Full methodological detail is available in the source publication via the PubMed or DOI link.

Results

Demonstrated incredibly significant and enduring systemic body fat and weight load reductions consistently across massively diversified international populations.

Limitations

Focused comprehensively upon strictly defined diagnostic criteria groups exclusively.

External links